Income Statement
LIFESTANCE HEALTH GROUP, INC.
LFST
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
1,424.29 | 1,250.97 | 1,055.67 | 859.54 | 667.51 |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
1,424.29 | 1,250.97 | 1,055.67 | 859.54 | 667.51 |
|
Operating Expenses
|
1,400.14 | 1,282.58 | 1,244.80 | 1,069.72 | 953.86 |
|
Research & Development
|
- | - | - | - | - |
|
Selling, General & Administrative
|
382.20 | 363.06 | 410.79 | 377.99 | 433.73 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
24.15 | -31.61 | -189.13 | -210.17 | -286.35 |
|
Non-Operating Income
|
-11.79 | -26.00 | -17.45 | -22.56 | -46.75 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
11.66 | 26.54 | 21.22 | 19.93 | 38.91 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
12.36 | -57.61 | -206.58 | -232.73 | -333.11 |
|
Income Tax Expense
|
2.70 | -0.17 | -20.32 | -17.17 | -25.91 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
9.66 | -57.44 | -186.26 | -215.56 | -307.20 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
78.90 | 39.34 | -108.70 | -140.98 | -232.22 |
|
Earnings Per Share (Basic)
|
- | - | - | - | - |
|
Diluted EPS
|
- | - | - | - | - |
|
Weighted Average Shares
|
386.02 | 379.15 | 0.37 | 0.36 | - |
|
Diluted Weighted Avg Shares
|
391.14 | 379.15 | 0.37 | - | - |
|
Comprehensive Income
|
8.73 | -58.82 | -187.23 | -212.29 | -307.20 |